The head of the Senate health panel used a hearing Thursday on President Donald Trump’s pick to lead the Food and Drug Administration to air his concerns about several of the administration’s health policies and perceived political interference, including recent plans to provide more political oversight of scientific research grants.
“These decisions must be made by people who understand science, not politicians,” said Sen. Bill Cassidy (R-La.), chair of the in front of the Senate Health, Education, Labor, and Pensions Committee. “I hope to see the White House decide against politicizing the approval process.”
Heidi Overton, deputy assistant …
Our editorial team includes several staff writers, each contributing their specialized knowledge to enhance the depth and breadth of our event and story coverage.